THOMAS GIGUIERE: Open Payments
NPI 1932468980 · ELIZABETH CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 17 payments from 10 companies in 2025. Trend: 2023 $149 · 2024 $355 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $100 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: VRAYLAR, QULIPTA, TRELEGY ELLIPTA, VOQUEZNA, GEMTESA, Wegovy, EVKEEZA, Korlym.
Industry payments across NC — which companies pay providers there.
